SCHEMBL6960235

SCHEMBL6960235

C1CNCCNCCCNCCNC1.O=[N+]([O-])c1nccn1CC1CO1

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TYMP P19971 3/20 0.41
KMT2A Q03164 1/20 0.40
CA12 O43570 5/20 0.39
CA1 P00915 5/20 0.39
CA2 P00918 5/20 0.39
CA9 Q16790 5/20 0.39
LMNA P02545 1/20 0.38
THRB P10828 1/20 0.38
CYP2C19 P33261 1/20 0.38
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
OPRK1 P41145 1/20 0.36
BRD4 O60885 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8855488 0.89 KMT2A (0.47) TYMPKMT2ACA12CA1CA2
SCHEMBL1614716 0.89 KMT2A (0.47) TYMPKMT2ACA12CA1CA2
SCHEMBL8897393 0.89 KMT2A (0.47) TYMPKMT2ACA12CA1CA2
Trifluoroacetic Acid SCHEMBL29174390 0.69 LMNA (0.40) TYMPKMT2ACA12CA1CA2
SCHEMBL11390072 0.68 CA12 (0.64) TYMPKMT2ACA12CA1CA2
SCHEMBL15597325 0.65 TYMP (0.56) TYMPKMT2ACA12CA1CA2
SCHEMBL9272320 0.65 KMT2A (0.54) TYMPKMT2ACA12CA1CA2
SCHEMBL8530813 0.65 LMNA (0.59) TYMPKMT2ACA12CA1CA2
SCHEMBL29579255 0.65 CA12 (0.53) TYMPKMT2ACA12CA1CA2
SCHEMBL16752479 0.65 CA12 (0.53) TYMPKMT2ACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1148878-A4 1,4,8,11-TETRAAZACYCLOTETRADECANE DERIVATIVES AS RADIODIGANOSTIC AGENTS AND THEIR USE IN DETERMINING HYPOXIA AND RADIORESISTANCE OF TUMORS FOX CHASE CANCER CT (US) 2003-04-02 EP disclosed
EP-1148878-A1 1,4,8,11-TETRAAZACYCLOTETRADECANE DERIVATIVES AS RADIODIGANOSTIC AGENTS AND THEIR USE IN DETERMINING HYPOXIA AND RADIORESISTANCE OF TUMORS FOX CHASE CANCER CENTER (US) 2001-10-31 EP disclosed
WO-2000043004-A1 1,4,8,11-TETRAAZACYCLOTETRADECANE DERIVATIVES AS RADIODIGANOSTIC AGENTS AND THEIR USE IN DETERMINING HYPOXIA AND RADIORESISTANCE OF TUMORS FOX CHASE CANCER CENTER (US) 2000-07-27 WO disclosed